BLACKROCK SMALLER COMPANIES TRUST PLC
All information is at 30 NOVEMBER 2012 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value* -0.2% 6.2% 17.8% 74.4% 48.9%
Share price* 1.8% 8.1% 27.0% 89.6% 63.7%
Numis ex Inv Companies + AIM* -0.1% 5.0% 13.7% 29.7% -0.4%
Sources: BlackRock and Datastream
At month end
Net asset value Capital only (debt at par value): 622.30p
Net asset value Capital only (debt at fair value): 618.13p
Net asset value incl. Income (debt at par value): 628.25p**
Net asset value incl. Income (debt at fair value): 624.07p**
Share price: 538.50p
Discount to Cum Income NAV (debt at par value): 14.3%
Discount to Cum Income NAV (debt at fair value): 13.7%
Net yield: 1.8%
Total assets^: £331.0m
Net gearing incl. Income (debt at fair value): 10.7%
2012 Total Expense Ratio ("TER")^^: 0.7%
Ordinary shares in issue#: 47,879,792
*performance calculations based on a capital only NAV with debt at par, without
income reinvested. Share price performance calculations exclude income
reinvestment.
**includes net revenue of 5.95p
^includes current year revenue
^^As reported in the Annual Financial Statements for the year ended
29 February 2012, the TER is calculated as a percentage of net assets and using
operating expenses, excluding performance fees, finance costs and taxation.
#excludes 2,113,731 shares held in treasury
Ten Largest Sector
Weightings % of total assets
Support Services 9.9
Software & Computer Services 9.0
Oil & Gas Producers 6.6
General Retailers 6.5
Electronic & Electrical Equipment 6.4
Financial Services 6.4
Chemicals 5.9
Travel & Leisure 5.4
Media 5.2
Household Goods & Home Construction 5.2
----
Total 66.5
====
Ten Largest Equity Investments (in alphabetical order)
Company
Ashtead
Aveva Group
AZ Electronic Materials
Bellway
Booker Group
Howden Joinery
Oxford Instruments
Senior
Victrex
Workspace
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During November the Company's NAV per share fell by 0.2% whilst the benchmark
index decreased by 0.1%. The FTSE 100 Index increased by 1.5%. (All performance
percentages have been calculated on a capital only basis.)
Sector allocation was slightly positive with our overweight position in
specialitychemicals companies contributing to relative performance. Stock
selection was marginally negative.
No stock contributed more than 0.25% to relative performance, positively or
negatively. Our largest contributor to negative stock selection in the month
was from a smaller holding, Brainjuicer. Brainjuicer warned profits would be
below expectations because large corporate customers had delayed spending on
market research tools late in the year. Interestingly, sales of Brainjuicer's
most innovative tools were up 39% in the 10 months to 31 October 2012 compared
to the prior period, but other research tools revenues were down 22% over the
same period. The company has net cash and a strong management team. We expect a
better performance next year and therefore we are retaining our holding.
We had good results, trading updates or meetings from/with various holdings
during the month including Oxford Instruments, Keller, Aveva, Hyder Consulting,
Big Yellow and Workspace.
There were no new holdings during the month. We continued to sell a number of
small holdings where we see limited near term upside.
13 December 2012
ENDS
Latest information is available by typing www.blackrock.co.uk/brsc on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.